Pricing
Zepbound® KwikPen® Pricing
Zepbound® KwikPen®
2.5 mg/0.6 mL (starting dose)
Zepbound® KwikPen® (tirzepatide) is an FDA-approved, once-weekly injectable GLP-1 medication used to manage weight gain. Average weight loss is 15-20% of body weight in 12 months.** Ready-to-use. No prep. No measuring.
Start NowMedLeanRx Weight Care
MedLeanRx Physician-Guided Care
Monthly fee includes unlimited messaging with your doctor, wellness check-ins, side-effect management, dose adjustments, and long-term planning.
- Unlimited messaging with your doctor
- Wellness check-ins
- Side-effect management
- Dose adjustments
- Long-term planning
**Average weight loss based on clinical trial data. Individual results may vary. Prescription approval is not guaranteed and is based on medical necessity and provider discretion.
*An active MedLeanRx membership is required ($99/month). Total cost includes the monthly membership fee and, if prescribed, the cost of medication. Membership and medication are billed separately, and a prescription is not guaranteed. Medication is available only after evaluation and approval by a licensed healthcare provider.
What Is It
Zepbound® KwikPen® (tirzepatide)
Zepbound® KwikPen® (tirzepatide) is a weight-loss medication proven effective at managing blood sugars and promoting weight loss. It is given as a weekly injection.
Zepbound® KwikPen® activates the receptors of two hormones — glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) — to help regulate blood sugar, curb appetite, and support sustainable weight loss.
On average, people lose 20% of their body weight in 12 months. Many users report changes in appetite in the first week.
Key Benefits
Ready-to-use
Easy, self-administered, pre-filled pen — no prep or measuring needed.
Sustainable weight loss
On average, people lose 20% of their body weight in 12 months.
See results in as little as 4 weeks
Many users report changes in appetite in the first week.
Dual-action mechanism
Targets both GIP and GLP-1 receptors for stronger appetite control and metabolic support.
What Is It
1-month supply of Zepbound® KwikPen® (tirzepatide). FDA-approved, once-weekly injectable GLP-1 + GIP medication.
Who Is It For
Adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. Eligibility determined by a licensed physician.
How To Get It
Prescription required. Complete your online assessment, get reviewed by a licensed physician within 24–48 hours, and receive medication shipped directly to your door.
How It Works
Getting Started with Zepbound®
From assessment to medication delivery — the entire process is online and physician-guided.
Complete Your Online Assessment
Answer a short 5-minute health questionnaire from your phone or computer. No clinic visit, no appointment needed.
Physician Reviews Your Profile
A licensed physician reviews your health history and determines whether Zepbound® (tirzepatide) is appropriate for you. Review completed within 24–48 hours.
Receive Your Personalized Treatment Plan
If approved, you receive a personalized Zepbound® treatment plan with your starting dose, titration schedule, and clear next steps.
Medication Shipped to Your Door
Your Zepbound® KwikPen® ships directly to your address — fast, discreet, and temperature-controlled. No pharmacy trips required.
No commitment required · 5 minutes · $99/mo + medication cost
FAQ
Zepbound® — Frequently Asked Questions
Ready to Start?
Start your Zepbound® weight loss program today
Complete your free online assessment and a licensed physician will review your health profile within 24–48 hours — no clinic visits, no waiting rooms.
Start My Free AssessmentTakes 5 minutes · No commitment required · $99/mo + medication cost